Insiders · Profile

ProQuest Investments IV, L.P.

10% owner at UroGen Pharma. Filing since 27 Nov 2017. CIK 0001431818

Company
Date
Role
Action
Shares
Amount
Of holding
28 Nov 2017
10% owner
Sold, plan not stated
177,807
$7.20M
12.5%
27 Nov 2017
10% owner
Sold, plan not stated
31,491
$1.29M
2.2%
2 decisions on file.